1505 Adams Dr., Ste. D
4 articles with BioPharmX
Not satisfied with the pharmaceutical industry's pace of change, BioPharmX picks team of 'best and brightest' experts to identify evolving needs of patients and physicians
BioPharmX Corporation reports financial results for the quarter ended April 30, 2018.
BioPharmX Studies Show Hydrophilic Topical Minocycline Gels May Be the Preferred Treatment Option for Acne, Rosacea Patients
For the first time, BioPharmX will share its research at the Congress of Clinical Dermatology
BioPharmX Corporation reports financial results for the quarter and year ended January 31, 2018.